D. Remick

Epidemiology · 2000–2011

A researcher in the Science corpus: 4 papers; trusts 8 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom D. Remick trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Mitchell M. Levy
  2. Derek C. Angus
  3. J. Buras
  4. N. Steigbigel
  5. C. Esmon
  6. J. Marshall

Who trusts D. Remick overall

  1. S. Sriskandan
  2. Michael Berk

Papers from D. Remick's perspective

Ordered by how strongly the researchers D. Remick trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care (Critical Care Medicine)
  2. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. (New England Journal of Medicine)
  3. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis (Intensive Care Medicine)
  4. Efficacy and safety of recombinant human activated protein C for severe sepsis. (New England Journal of Medicine)
  5. The pathophysiology and treatment of sepsis. (New England Journal of Medicine)
  6. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference (Intensive Care Medicine)
  7. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
  8. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. (Journal of the American Medical Association (JAMA))
  9. Intensive insulin therapy in critically ill patients. (New England Journal of Medicine)
  10. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. (Journal of the American Medical Association (JAMA))

Their papers